16564029|t|Colivelin prolongs survival of an ALS model mouse.
16564029|a|Amyotrophic lateral sclerosis (ALS) is the most common motor neuron disease for which there is no sufficiently effective therapy. We have reported in our earlier study that intracerebroventricular (i.c.v.) injection of activity-dependent neurotrophic factor (ADNF) improves motor performance of G93A-SOD1 transgenic mice without significant prolongation in survival. Here, we found that i.c.v. injection of a synthetic hybrid peptide named Colivelin composed of ADNF and AGA-(C8R)HNG17, a potent derivative of Humanin that is a bioactive peptide with anti-Alzheimer's disease activity, dose-dependently improved motor performance and prolonged survival of ALS mice. Histological analysis, performed at the age of 120 days, demonstrated increased motoneuronal survival in spinal cords of Colivelin-treated mice as compared with saline- or ADNF-treated mice, indicating that Colivelin is a promising neurotrophic peptide for treatment of ALS.
16564029	34	37	ALS	Disease	MESH:D000690
16564029	44	49	mouse	Species	10090
16564029	51	80	Amyotrophic lateral sclerosis	Disease	MESH:D000690
16564029	82	85	ALS	Disease	MESH:D000690
16564029	106	126	motor neuron disease	Disease	MESH:D016472
16564029	346	350	G93A	DNAMutation	tmVar:c|SUB|G|93|A;HGVS:c.93G>A;VariantGroup:0;OriginalGene:20655;CorrespondingGene:6647;CorrespondingSpecies:10090
16564029	351	355	SOD1	Gene	20655
16564029	367	371	mice	Species	10090
16564029	522	526	AGA-	Gene	11593
16564029	561	568	Humanin	Species	
16564029	607	626	Alzheimer's disease	Disease	MESH:D000544
16564029	707	710	ALS	Disease	MESH:D000690
16564029	711	715	mice	Species	10090
16564029	856	860	mice	Species	10090
16564029	902	906	mice	Species	10090
16564029	987	990	ALS	Disease	MESH:D000690
16564029	Negative_Correlation	MESH:D000544	11593

